Liber Pharmaceuticals is a proudly independent, Australian owned and operated manufacturer of high quality personal nicotine vaporisers and pharmaceutical grade e-liquids. Liber Pharmaceuticals has no affiliation with any tobacco manufacturing corporation. Indeed, our products are manufactured with a primary focus on smoking cessation and reducing the harms caused by smoking.
Approximately 70% of Australian smokers say they want to quit smoking, but for a number of reasons don’t, or simply can’t. They need viable alternatives they can trust, understand and easily use to successfully transition away from smoking completely.
Liber Pharmaceuticals’ Nicovape Q devices and liquids are manufactured to the highest possible standards. Wherever possible, we use medical or pharmaceutical standards as the benchmarks for our products. By continuing to focus on quality, safety, efficacy and user experience, Liber Pharmaceuticals intends to pave the way towards a product suitable for medical registration.
Liber Pharmaceuticals pioneered the world's first medically prescribed ENDS service. Since inception we have required medical supervision as an integral step in accessing our Nicovape branded products. We believe the support of a medical professional is the key to encouraging long-term smokers to commence, and continue, their journey away from smoking.
We recognise that while these products can help achieve the goal of a smoke-free Australia, they should not be accessible to youth or non-smokers. Providing access to these products via Pharmacies creates an additional touchpoint of support for smokers and prevents access by youth and non-smokers.
The team at Liber Pharmaceuticals is committed to helping improve smoking cessation rates nationwide and will continue to work in collaboration with medical, scientific and public health stakeholders to ensure that we stay at the very forefront of ENDS technology and innovation.
